In vivo studies using Wistar rats, mice, and Gottingen minipigs demonstrated that TTP399 does not activate glucokinase in pancreatic β-cells, does not alter insulin secretion, and does not result in hypoglycemia [51]. Here, GCK is linked to Hypoglycemia.